Afya (NASDAQ:AFYA - Get Free Report) is projected to announce its Q1 2025 earnings results before the market opens on Thursday, May 8th. Analysts expect Afya to post earnings of $0.46 per share and revenue of $923.11 million for the quarter.
Afya Price Performance
AFYA traded up $0.11 on Tuesday, reaching $19.06. The company had a trading volume of 141,556 shares, compared to its average volume of 123,215. The company has a debt-to-equity ratio of 0.51, a quick ratio of 1.60 and a current ratio of 1.60. Afya has a 52-week low of $14.52 and a 52-week high of $20.06. The company has a market cap of $1.79 billion, a price-to-earnings ratio of 15.37, a P/E/G ratio of 0.29 and a beta of 0.60. The business has a 50 day simple moving average of $17.77 and a 200 day simple moving average of $16.85.
Afya Dividend Announcement
The business also recently disclosed a -- dividend, which was paid on Friday, April 4th. Stockholders of record on Wednesday, March 26th were issued a dividend of $0.232 per share. The ex-dividend date of this dividend was Wednesday, March 26th. Afya's dividend payout ratio is currently 17.69%.
Analyst Ratings Changes
A number of equities analysts have recently issued reports on the company. Morgan Stanley cut Afya from an "equal weight" rating to an "underweight" rating and cut their price objective for the stock from $19.00 to $17.00 in a report on Tuesday, March 11th. JPMorgan Chase & Co. decreased their price target on shares of Afya from $25.00 to $20.50 and set a "neutral" rating on the stock in a research note on Friday, January 17th. Finally, Citigroup reaffirmed a "sell" rating and issued a $15.00 price objective (down previously from $18.00) on shares of Afya in a research note on Friday, January 31st. Three analysts have rated the stock with a sell rating and two have issued a hold rating to the company. According to data from MarketBeat, the company currently has a consensus rating of "Reduce" and an average price target of $17.60.
Read Our Latest Stock Report on AFYA
Afya Company Profile
(
Get Free Report)
Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.
Featured Stories

Before you consider Afya, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Afya wasn't on the list.
While Afya currently has a Strong Sell rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.